Equibles does not estimate personal net worth.
Earlier roles on record: CEO at Aptargroup, Inc. (ATR) until September 1, 2026. Aptargroup, Inc. reported in an 8-K filed March 17, 2026 that Stephan Tanda resigned as member of the Board, effective December 31, 2026. Aptargroup, Inc. reported in an 8-K filed March 17, 2026 that Stephan Tanda retired as executive (retiring), effective March 16, 2026. Aptargroup, Inc. reported in an 8-K filed March 17, 2026 that Stephan Tanda retired as President and Chief Executive Officer, effective September 1, 2026. The proxy statement of Aptargroup, Inc. reports total compensation of $7,018,822 for Stephan Tanda in fiscal 2020, including a base salary of $1,105,000. Disclosed compensation is on record for 3 fiscal years. Stephan Tanda has spoken on 26 earnings calls and 1 other investor event across 1 company, most recently for Aptargroup, Inc. on July 31, 2026. The companies whose calls Stephan Tanda spoke on are classified in the Healthcare sector.
“provided, that you will continue to serve as a member of the Board until December 31, 2026 (or your earlier termination of employment for any reason), at which time you shall be deemed to have resigned from the Board.”
“This letter memorializes your notification to the Board of Directors (the "Board") on March 16, 2026 of your decision to retire.”
“As many of you know, this is my final earnings call as CEO of Aptar before I will retire later this year. It has been a tremendous honor to lead this company and work alongside our talented teams around the world.”
“We appreciate you joining us on the call today. As previously announced, I will be retiring later this year, and we will welcome Gael Tuya as AFDAR's next CEO on September 1.”
“Fundamentally, we have a best-in-class leading proprietary drug delivery system business. And basically, if it goes through the nose, it goes through Aptar.”
“We appreciate you joining us on the call today. I will begin my remarks by highlighting our annual and fourth quarter results. And later in the call, our CFO, Vanessa Kanu, will provide additional details on the key drivers for the quarter.”
“We appreciate you joining us on the call today. I will begin my remarks by highlighting our third quarter results. Later in the call, Vanessa Canu, our CFO, will provide additional details on key drivers for the quarter.”
Start not stated–2026-09-01
ATR
Medical Instruments & Supplies · Healthcare
CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Aptargroup, Inc. (ATR) | CEO | $1,105,000 | $7,018,822 |
| 2019 | Aptargroup, Inc. (ATR) | CEO | $1,071,200 | $7,918,040 |
| 2018 | Aptargroup, Inc. (ATR) | CEO | $1,030,000 | $8,039,185 |
